Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia.

[1]  F. Boureau,et al.  Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial , 2003, Pain.

[2]  T. Travison,et al.  Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial , 2002, Neurology.

[3]  Francis J. Keefe,et al.  The Management of Persistent Pain in Older Persons , 2002 .

[4]  A. Rice,et al.  Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study , 2001, PAIN.

[5]  J. Haythornthwaite,et al.  Psychological Aspects of Neuropathic Pain , 2000, The Clinical journal of pain.

[6]  C. Bonezzi,et al.  Treatment options in postherpetic neuralgia , 1999, Acta neurologica Scandinavica. Supplementum.

[7]  G. Cooper,et al.  The sensitivity of Medicare claims data for case ascertainment of six common cancers. , 1999, Medical care.

[8]  M. Rowbotham,et al.  Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. , 1998, JAMA.

[9]  G. Cooper,et al.  Use of medicare claims data to measure county‐level variations in the incidence of colorectal carcinoma , 1998, Cancer.

[10]  S. Straus,et al.  Postherpetic neuralgia--pathogenesis, treatment, and prevention. , 1996, The New England journal of medicine.

[11]  M. Max.  Treatment of post‐herpetic neuralgia: Antidepressants , 1994, Annals of neurology.

[12]  E. DeLong,et al.  Discordance of Databases Designed for Claims Payment versus Clinical Information Systems: Implications for Outcomes Research , 1993, Annals of Internal Medicine.

[13]  S. Leatherman,et al.  Using Claims Data for Epidemiologic Research: The Concordance of Claims-Based Criteria With the Medical Record and Patient Survey for Identifying a Hypertensive Population , 1993, Medical care.

[14]  G. Benedittis,et al.  A new topical treatment for acute herpetic neuralgia and post-herpetic neuralgia: the aspirin/diethyl ether mixture. An open-label study plus a double-blind controlled clinical trial , 1992, Pain.

[15]  E. Fisher,et al.  The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. , 1992, American journal of public health.

[16]  M. Rowbotham,et al.  Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia , 1991, Neurology.

[17]  H. Wheeler.  Healing and Heroism , 1990 .

[18]  C Peter N Watson,et al.  Post-herpetic neuralgia: 208 cases , 1988, Pain.

[19]  R. Elashoff,et al.  Flaws in mortality data. The hazards of ignoring comorbid disease. , 1988, JAMA.

[20]  D. K. Williams,et al.  Assessing hospital-associated deaths from discharge data. The role of length of stay and comorbidities. , 1988, JAMA.

[21]  R. Dubner,et al.  Amitriptyline, but not lorazepam, relieves postherpetic neuralgia , 1988, Neurology.

[22]  R. Dubner,et al.  Association of pain relief with drug side effects in postherpetic neuralgia: A single‐dose study of clonidine, codeine, ibuprofen, and placebo , 1988, Clinical pharmacology and therapeutics.

[23]  Hsia Dc,et al.  Accuracy of Diagnostic Coding for Medicare Patients under the Prospective-Payment System , 1988 .

[24]  R. Portenoy,et al.  Acute herpetic and postherpetic neuralgia: Clinical review and current management , 1986, Annals of neurology.

[25]  M. Thompson,et al.  Nontraditional analgesics for the management of postherpetic neuralgia. , 1985, Clinical pharmacy.

[26]  G. Brown.  Herpes Zoster: Correlation of Age, Sex, Distribution, Neuralgia, and Associated Disorders , 1976, Southern medical journal.

[27]  R. Kierland,et al.  The outcome of patients with herpes zoster. , 1957, A.M.A. archives of dermatology.

[28]  B. Gordon.  Current procedural terminology , 1966 .